支气管动脉介入治疗肺鳞状细胞癌一例

A case of bronchial artery interventional therapy for pulmonary squamous cell carcinoma

ES评分 0

DOI 10.12208/j.ijcr.20220087
刊名
International Journal of Clinical Research
年,卷(期) 2022, 6(2)
作者
作者单位

梓潼县人民医院 四川绵阳 ;

摘要
病史摘要 患者,男,73岁,因“反复咳嗽、咳痰8+年,间断痰中带血半年”入院。入院后拟行支气管镜检查,明确病理类型,支气管镜检查前反复咯血,给予止血治疗后无好转,为减少活检出血风险及止血,给予经导管支气管动脉栓塞(BAE),栓塞后患者咯血停止,行支气管镜检查,术中出血少,活检顺利;支气管镜病理检查:(右下叶)非小细胞恶性肿瘤,鳞状细胞癌。明确诊断后转肿瘤科静脉化疗。后期随访:患者在肿瘤科静脉化疗5次后出现化疗副作用,因不愿继续静脉化疗,给予经导管支气管动脉灌注化疗(BAI),副作用小,效果良好。
Abstract
Medical history summary: The patient, male, 73 years old, was admitted to the hospital for "repeated coughing, sputum coughing for more than eight years,intermittent sputum with blood for half a year". Bronchoscopy is proposed after admission to determine the type of pathology. In order to reduce the risk of bleeding on biopsy, we given transcatheter bronchial artery embolization (BAE), after transembolization, patients stop hemoptysis, Bronchoscopy was performed with little intraoperative bleeding and smooth biopsy. postoperative bronchoscopy: (lower right lobe) non-small cell malignancy, squamous cell carcinoma. After a definitive diagnosis, the patient underwent intravenous chemotherapy in the oncology department. Later follow-up: patients who had chemotherapy side effects after 5 intravenous chemotherapy sessions in the oncology department were reluctant to continue intravenous chemotherapy,he was given transcatheter bronchial artery perfusion chemotherapy (BAI), which had few side effects and good results.
关键词
支气管镜检查;鳞状细胞癌;导管支气管动脉灌注化疗
KeyWord
bronchoscopy; squamous cell carcinoma; catheter bronchial artery infusion chemotherapy
基金项目
页码 186-189
  • 参考文献
  • 相关文献
  • 引用本文

杨林,任元亮*,仇松,林罗强. 支气管动脉介入治疗肺鳞状细胞癌一例 [J]. 国际临床研究杂志. 2022; 6; (2). 186 - 189.

  • 文献评论

相关学者

相关机构